"🐝Restore vitality and bid farewell to joint pain! Try our brand new product - New Zealand Bee Venom Joint and Bone Therapy Cream.
Whether it's orthopedic conditions or arthritis pain, it brings you the hope of recovery in just 3-6 weeks.
Our advanced formula combines pure bee venom, glucosamine, chondroitin, and MSM to effectively reduce pain and stiffness, and promote circulation and healing. In just a few weeks, you will feel a complete rejuvenation of your bones and joints.
"🐝Restore vitality and bid farewell to joint pain! Try our brand new product - New Zealand Bee Venom Joint and Bone Therapy Cream.
Whether it's orthopedic conditions or arthritis pain, it brings you the hope of recovery in just 3-6 weeks.
Our advanced formula combines pure bee venom, glucosamine, chondroitin, and MSM to effectively reduce pain and stiffness, and promote circulation and healing. In just a few weeks, you will feel a complete rejuvenation of your bones and joints.
The STAR Market, as is implied by the name, is heavily geared toward smaller innovative tech companies, in particular those engaged in strategically important fields, such as biopharmaceuticals, 5G technology, semiconductors, and new energy. The STAR Market currently has 340 listed securities. The STAR Market is seen as important for China’s high-tech and emerging industries, providing a space for smaller companies to raise capital in China. This is especially significant for technology companies that may be viewed with suspicion on overseas stock exchanges.
Pinterest (PINS) Stock Sinks As Market Gains
Pinterest (PINS) closed at $71.75 in the latest trading session, marking a -0.18% move from the prior day. This change lagged the S&P 500's daily gain of 0.1%. Meanwhile, the Dow gained 0.9%, and the Nasdaq, a tech-heavy index, lost 0.59%.
Heading into today, shares of the digital pinboard and shopping tool company had lost 17.41% over the past month, lagging the Computer and Technology sector's loss of 5.38% and the S&P 500's gain of 0.71% in that time.
Investors will be hoping for strength from PINS as it approaches its next earnings release. The company is expected to report EPS of $0.07, up 170% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $467.87 million, up 72.05% from the year-ago period.
